Stephen C. Turner

Stephen C. Turner discloses dealings in Protea Biosciences Group, Inc. to SEC (Form 4). Over a trading history stretching from 30 July 2013 to 3 November 2016, the count stands at 5 filings.

The open-market record is one-sided, with 4 purchases worth €6,030 and not one sale. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. So far in 2016, the count stands at 2 purchases and no sales.

The latest filing, published on 7 November 2016, reports a share grant of €36k in Protea Biosciences Group, Inc. The last purchase on record was published on 27 July 2016, which is 3,740 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.